Baird R W Upgrades Astrana Health (NASDAQ:ASTH) to “Strong-Buy”

Baird R W upgraded shares of Astrana Health (NASDAQ:ASTHFree Report) to a strong-buy rating in a research report released on Thursday morning, reports.

Other equities research analysts also recently issued reports about the stock. Stifel Nicolaus lowered their price objective on shares of Astrana Health from $50.00 to $45.00 and set a buy rating for the company in a research note on Wednesday, May 8th. Jefferies Financial Group started coverage on Astrana Health in a research report on Monday, February 26th. They set a buy rating and a $50.00 price target for the company. Truist Financial increased their price objective on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a report on Friday, March 1st. Finally, Robert W. Baird assumed coverage on Astrana Health in a report on Thursday. They set an outperform rating and a $54.00 target price for the company. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from, the company presently has an average rating of Buy and an average target price of $48.25.

Get Our Latest Report on Astrana Health

Astrana Health Price Performance

Shares of NASDAQ:ASTH opened at $41.43 on Thursday. The company’s 50-day simple moving average is $39.43. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.56. Astrana Health has a 1 year low of $28.86 and a 1 year high of $45.71. The firm has a market cap of $2.32 billion, a price-to-earnings ratio of 31.39, a P/E/G ratio of 1.29 and a beta of 1.12.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). The company had revenue of $404.36 million for the quarter, compared to analyst estimates of $413.84 million. Astrana Health had a net margin of 4.29% and a return on equity of 10.22%. The business’s revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.42 EPS. On average, analysts expect that Astrana Health will post 1.62 EPS for the current year.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Read More

Analyst Recommendations for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with's FREE daily email newsletter.